Viz.ai Debuts Viz ANX Cerebral Aneurysm Detection Solution

November 17, 2021—Viz.ai announced the introduction of Viz ANX, the company’s artificial intelligence (AI)–powered suspected cerebral aneurysm detection and care coordination platform. The company also introduced Viz SDH, a research-only algorithm supporting the EMBOLISE trial that detects suspected subdural hematoma (SDH) to alert clinicians to potentially eligible study candidates.

Viz.ai announced these developments at SVIN 2021, the Society of Vascular and Interventional Neurology annual meeting in Phoenix, Arizona.

According to the company, Viz ANX uses AI to detect and alert the appropriate care providers of newly detected aneurysms on CTAs. The 510(k)-pending Viz ANX algorithm will be the first AI software to automatically detect suspected aneurysms. The solution ensures that these aneurysms are captured in an easily accessible and reviewable list and enables one-click referrals to a clinic for follow-up, saving valuable time and resources for physicians and helping ensure patients receive proper treatment.

Additionally, Viz.ai noted that the purpose of the EMBOLISE study is to evaluate the safety and efficacy of embolization of the middle meningeal artery using the Onyx liquid embolic system (Medtronic) for the treatment of symptomatic subacute or chronic subdural hematoma. The SDH algorithm, which includes volumetric segmentation of and measurement of the maximum thickness of the bleed, detects suspected SDH to alert clinicians to potentially eligible study candidates.

Ameer Hassan, DO, who is Head of Neuroscience at Valley Baptist in Harlingen, Texas, and President-Elect of SVIN, commented in the company’s press release, “We know that the Viz platform is widely successful at leveraging AI to help improve workflows and improve patient outcomes in stroke. But stroke is just a proof point for how AI can transform patient care and clinical research. By applying the same technology to indications such as aneurysm, I believe we will see further areas of health care transformed for better outcomes.”

Viz.ai is showcasing the new Viz ANX and Viz SDH, along with the complete Viz Intelligent Care Coordination Platform, at SVIN 2021. Also, at SVIN, the company will host a symposium entitled, “The impact of artificial intelligence on vascular interventional neurology. Today into the future,” featuring Dr. Hassan and Raul Noguiera, MD, who is Director of Neuroendovascular Service and Neurocritical Care Service at Marcus Stroke & Neuroscience Center, Grady Memorial Hospital in Atlanta, Georgia.